SNPs in ERCC1 and drug response to cisplatin in non-small-cell lung cancer patients

Pharmacogenomics. 2011 Apr;12(4):445-7. doi: 10.2217/pgs.11.15.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Pharmacological*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Cisplatin / therapeutic use*
  • DNA-Binding Proteins / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • Endonucleases / genetics*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Polymorphism, Single Nucleotide

Substances

  • Antineoplastic Agents
  • Biomarkers, Pharmacological
  • DNA-Binding Proteins
  • ERCC1 protein, human
  • Endonucleases
  • Cisplatin